John P. Lambooy

659 total citations
54 papers, 423 citations indexed

About

John P. Lambooy is a scholar working on Molecular Biology, Biochemistry and Clinical Biochemistry. According to data from OpenAlex, John P. Lambooy has authored 54 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Biochemistry and 15 papers in Clinical Biochemistry. Recurrent topics in John P. Lambooy's work include Metabolism and Genetic Disorders (15 papers), Amino Acid Enzymes and Metabolism (14 papers) and Cancer, Hypoxia, and Metabolism (6 papers). John P. Lambooy is often cited by papers focused on Metabolism and Genetic Disorders (15 papers), Amino Acid Enzymes and Metabolism (14 papers) and Cancer, Hypoxia, and Metabolism (6 papers). John P. Lambooy collaborates with scholars based in United States. John P. Lambooy's co-authors include Edward E. Haley, Kim Ys, H. Vasken Aposhian, Robert Faulkner, Robert A. Scala, C.S. Shaffner, Mary M. Aposhian, Boyd M. Koffman, Winfield Hill and K. A. Kilpatrick and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and American Journal of Clinical Nutrition.

In The Last Decade

John P. Lambooy

53 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John P. Lambooy United States 12 159 120 119 78 65 54 423
D.W. Fanshier United States 10 207 1.3× 122 1.0× 45 0.4× 28 0.4× 42 0.6× 12 356
Petronio Pasquali Italy 12 364 2.3× 44 0.4× 39 0.3× 75 1.0× 93 1.4× 35 474
Floyd P. Kupiecki United States 15 263 1.7× 110 0.9× 39 0.3× 117 1.5× 80 1.2× 24 526
Shigeyuki Takeyama Japan 10 239 1.5× 36 0.3× 27 0.2× 30 0.4× 52 0.8× 45 408
E. S. Hall United States 9 170 1.1× 77 0.6× 116 1.0× 58 0.7× 178 2.7× 13 471
A. Schneider United States 7 199 1.3× 58 0.5× 27 0.2× 89 1.1× 44 0.7× 10 380
Hiroshi Kumaoka Japan 16 532 3.3× 177 1.5× 97 0.8× 13 0.2× 21 0.3× 35 718
Peter Pfaender Germany 10 234 1.5× 44 0.4× 36 0.3× 34 0.4× 78 1.2× 28 450
Erwin Schwenk United States 16 320 2.0× 55 0.5× 15 0.1× 32 0.4× 95 1.5× 33 658
Marie Fang United States 8 244 1.5× 57 0.5× 73 0.6× 103 1.3× 24 0.4× 9 448

Countries citing papers authored by John P. Lambooy

Since Specialization
Citations

This map shows the geographic impact of John P. Lambooy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Lambooy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Lambooy more than expected).

Fields of papers citing papers by John P. Lambooy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Lambooy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Lambooy. The network helps show where John P. Lambooy may publish in the future.

Co-authorship network of co-authors of John P. Lambooy

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Lambooy. A scholar is included among the top collaborators of John P. Lambooy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Lambooy. John P. Lambooy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lambooy, John P. & Boyd M. Koffman. (1985). 4-Dimethylaminoazobenzenes: Carcinogenicities and reductive cleavage by microsomal azo reductase. Chemico-Biological Interactions. 53(1-2). 107–120. 5 indexed citations
2.
Lambooy, John P., et al.. (1985). Covalent bonding of riboflavin homologs by hepatic mitochondrial membrane enzymes. International Journal of Biochemistry. 17(9). 975–981. 3 indexed citations
3.
Lambooy, John P.. (1978). Syntheses and biological activities of basically substituted isoalloxazines. Journal of Medicinal Chemistry. 21(3). 301–303. 6 indexed citations
4.
Lambooy, John P. & C.S. Shaffner. (1977). Utilization of Analogues of Riboflavin by the Riboflavin-deficient Chick Embryo. Journal of Nutrition. 107(2). 245–250. 8 indexed citations
5.
6.
Lambooy, John P., et al.. (1973). The reduction of succinic dehydrogenase in the rat by 7-methyl-8-ethylflavin. Archives of Biochemistry and Biophysics. 159(1). 378–382. 9 indexed citations
7.
Lambooy, John P.. (1972). Synthesis and Biological Activity of 7-Methyl-8-bromo-10-(1-d-ribityl)iso-alloxazine, an Analog of Riboflavin. Experimental Biology and Medicine. 141(3). 948–952. 2 indexed citations
8.
Lambooy, John P., et al.. (1971). Utilization of 7-Chloro-8-methyl-flavin in the Rat and Its Specific Antiriboflavin Action in the Kidney. Journal of Nutrition. 101(9). 1137–1145. 4 indexed citations
9.
Lambooy, John P., et al.. (1970). Nondisplacement of Rat Tissue Riboflavin by 7-Chloro-8-methyl-flavin and the Stimulation of Intestinal Synthesis of Riboflavin. Journal of Nutrition. 100(8). 883–891. 2 indexed citations
10.
Hill, Winfield & John P. Lambooy. (1970). The Effect of a Vitaminlike Homolog of Riboflavin on Succinic Acid Dehydrogenase Activity of Brain. Experimental Biology and Medicine. 134(4). 922–925. 3 indexed citations
11.
Lambooy, John P., et al.. (1970). A study of the carcinogenicity of a series of structurally related 4-dimethylaminoazobenzenes.. PubMed. 30(5). 1520–4. 3 indexed citations
12.
Lambooy, John P.. (1966). The utilization of riboflavin antagonists by a mutant of Lactobacillus casei. Archives of Biochemistry and Biophysics. 117(1). 120–124. 3 indexed citations
13.
Lambooy, John P.. (1961). Growth Promoting Properties of 6-Ethyl-7-methyl-9-(1′-D-ribityl)isoalloxazine and 6-Methyl-7-ethyl-9-(1′-D-ribityl)isoalloxazine. Journal of Nutrition. 75(1). 116–126. 13 indexed citations
14.
Lambooy, John P., Robert A. Scala, & Edward E. Haley. (1961). The Biological Activities of 6-Methyl-7-chloro-9-(1′-D-ribityl)isoalloxazine and Dichlororiboflavin. Journal of Nutrition. 74(4). 466–472. 7 indexed citations
15.
Faulkner, Robert & John P. Lambooy. (1961). Intestinal Synthesis of Riboflavin in the Rat. Journal of Nutrition. 75(4). 373–378. 14 indexed citations
16.
Scala, Robert A. & John P. Lambooy. (1958). Utilization of the riboflavine inhibitor 6-chloro-7-methyl-9-(1′-d-ribityl)isoalloxazine by Lactobacillus casei. Archives of Biochemistry and Biophysics. 78(1). 10–14. 7 indexed citations
17.
Aposhian, H. Vasken & John P. Lambooy. (1955). The in vivo Synthesis of Diethylriboflavin Phosphate1,2. Journal of the American Chemical Society. 77(23). 6368–6368. 6 indexed citations
18.
Lambooy, John P.. (1955). Riboflavin Antagonists. American Journal of Clinical Nutrition. 3(4). 282–290. 5 indexed citations
19.
Lambooy, John P. & Edward E. Haley. (1952). Additional o-Phenylenediamines Tested for Vitamin B12 Activity. Journal of the American Chemical Society. 74(4). 1087–1089. 5 indexed citations
20.
Lambooy, John P.. (1951). ACTIVITY OF 6,7-DIETHYL-9-(d-1'-RIBITYL)-ISOALLOXAZINE FOR LACTOBACILLUS CASEI. Journal of Biological Chemistry. 188(2). 459–462. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026